A major breakthrough in cancer research is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This essential tumor protector protein is frequently disabled in several types of cancer, leading https://sirketlist.com/story23789945/mini-antibodies-revive-p53-a-promising-approach-for-malignant-therapy